bit.ly/bukujsitera02
Chapter 1: Introduction
1.1 Overview of the Book
1.2 The Natural Wealth of Sumatra
1.3 The Intersection of Biodiversity and Medicine
Chapter 2: Historical Perspectives
2.1 Traditional Use of Sumatran Natural Resources
2.2 Evolution of Natural Product Drug Discovery
Chapter 3: Sumatra’s Biodiversity
3.1 Flora of Sumatra
3.2 Fauna of Sumatra
3.3 Unique Ecosystems of Sumatra
Chapter 4: Plant-based Medicine
4.1 Overview of Phytotherapy
4.2 Sumatran Medicinal Plants and Their Traditional Uses
Chapter 5: Alkaloids in Drug Development
5.1 Overview of Alkaloids
5.2 Sumatran Plants as Alkaloid Sources
Chapter 6: Terpenes and Their Therapeutic Potential
6.1 Overview of Terpenes
6.2 Sumatran Plants as Terpene Sources
Chapter 7: Tannins and Polyphenols in Medicine
7.1 Overview of Tannins and Polyphenols
7.2 Sumatran Plants as Sources
Chapter 8: Bioactive Compounds from Sumatran Fauna
8.1 Venomous and Poisonous Creatures
8.2 Medicinal Insects and Other Small Creatures
Chapter 9: Fungi and Their Therapeutic Compounds
9.1 Overview of Medicinal Fungi
9.2 Sumatran Fungi as Sources of Therapeutic Compounds
Chapter 10: Bacterial and Viral Bioprospecting
10.1 Overview of Microbial Therapeutics
10.2 Sumatran Microbiota and Their Potential
Chapter 11: Marine Resources for Drug Development
11.1 Ocean's Pharmacy: An Overview
11.2 Sumatra's Marine Biota
Chapter 12: Ethnopharmacology in Sumatra
12.1 The Role of Indigenous Knowledge
12.2 Case Studies from Sumatra
Chapter 13: Bioprospecting and Biodiscovery Process
13.1 Overview of Bioprospecting
13.2 Opportunities in Sumatra
Chapter 14: Preclinical Drug Development
14.1 From Bench to Bedside: An Overview
14.2 Preclinical Models and Sumatran Compounds
Chapter 15: Clinical Trials and Regulation
15.1 Understanding Clinical Trials
15.2 Regulatory Landscape for Natural Product Drugs
Chapter 16: Sustainability and Conservation
16.1 Importance of Biodiversity Conservation
16.2 Sustainable Harvesting and Cultivation
Chapter 17: Intellectual Property Rights
17.1 Understanding Intellectual Property Rights in Drug Discovery
17.2 Case Studies from Sumatra
Chapter 18: Economic Perspectives
18.1 Economics of Drug Development
18.2 Sumatra’s Natural Wealth and the Global Economy
Chapter 19: Community Empowerment
19.1 The Role of Local Communities in Drug Discovery
19.2 Case Studies of Empowerment in Sumatra
Chapter 20: Policy Recommendations
20.1 Policymaking for Sustainable Drug Discovery
20.2 Sumatra-Specific Recommendations
Chapter 21: Advances in Biotechnology for Drug Discovery
21.1 Biotechnology Tools in Drug Development
21.2 Potential Applications for Sumatran Bioresources
Chapter 22: Systems Pharmacology and Natural Products
22.1 Understanding Systems Pharmacology
22.2 Applications for Natural Product Drug Discovery
Chapter 23: Bioinformatics and Drug Discovery
23.1 The Role of Bioinformatics in Drug Discovery
23.2 Bioinformatics Resources for Sumatra's Natural Wealth
Chapter 24: Challenges in Natural Drug Development
24.1 General Challenges
24.2 Challenges Specific to Sumatra's Bioresources
Chapter 25: Success Stories in Natural Drug Development
25.1 General Success Stories
25.2 Success Stories from Sumatra's Natural Wealth
Chapter 26: Future Directions in Drug Development
26.1 Trends in Drug Discovery
26.2 Sumatra’s Role in Future Drug Development
Chapter 27: Health and Wellness Applications
27.1 Overview of Natural Product Use in Wellness
27.2 Sumatra's Potential Contribution
Chapter 28: Sumatran Natural Wealth in the Global Context
28.1 Sumatra in the Global Pharmaceutical Industry
28.2 Global Implications of Sumatra's Biodiversity Loss
Chapter 29: Conclusions
29.1 Key Takeaways
29.2 Final Thoughts